NVCT (Nuvectis Pharma) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVCT Nuvectis Pharma Inc NVCT
30 GF Score
Price $18.75
! 1 Warning Sign
View Full Analysis

What is Nuvectis Pharma Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

NVCT
30GF Score
Nuvectis Pharma Inc NVCT
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuvectis Pharma Business Description

Address 1 Bridge Plaza, 2nd Floor, Suite 275, Fort Lee, NJ, USA, 07024
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
30GF Score

Get the complete analysis for NVCT

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.75
Price